Imitators of severe preeclampsia

Baha M Sibai1

  • 1Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA. baha.sibai@uc.edu

Insights

Severe preeclampsia mimics are dangerous pregnancy complications. Accurate diagnosis is crucial for appropriate management and improved outcomes for mothers and infants.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Critical Care Medicine

Background:

  • Several obstetric, medical, and surgical disorders mimic severe preeclampsia-hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome.
  • These conditions are life-threatening emergencies during pregnancy or postpartum, associated with high maternal mortality and long-term sequelae.
  • Pathophysiologic abnormalities often include thrombotic microangiopathy, thrombocytopenia, and hemolytic anemia.

Purpose of the Study:

  • To review the diagnosis, management, and counseling of pregnant and postpartum women with conditions imitating severe preeclampsia-HELLP syndrome.
  • To differentiate these rare but serious conditions from severe preeclampsia-HELLP syndrome based on current literature.

Main Methods:

  • Review of case reports and case series due to the rarity of these conditions.
  • Focus on differential diagnosis, management strategies, and counseling based on recent studies.

Main Results:

  • Differential diagnosis is challenging due to overlapping clinical and laboratory findings.
  • Management varies significantly; delivery is indicated for severe preeclampsia and acute fatty liver of pregnancy, while pregnancy may continue in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and systemic lupus erythematosus exacerbations.

Conclusions:

  • Accurate diagnosis of preeclampsia mimics is critical for appropriate management and improved maternal and perinatal outcomes.
  • Clinicians must be aware of these rare conditions and their distinct treatment protocols.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...